Tailoring epilepsy treatment: personalized micro-physiological systems illuminate individual drug responses

Introduction: Approximately 50 million people worldwide have epilepsy, with many not achieving seizure freedom. Organ-on-chip technology, which mimics organ-level physiology, could revolutionize drug development for epilepsy by replacing animal models in preclinical studies. The authors’ goal is to determine if customized micro-physiological systems can lead to tailored drug treatments for epileptic patients. Materials and methods: A comprehensive literature search was conducted utilizing various databases, including PubMed, Ebscohost, Medline, and the National Library of Medicine, using a predetermined search strategy. The authors focused on articles that addressed the role of personalized micro-physiological systems in individual drug responses and articles that discussed different types of epilepsy, diagnosis, and current treatment options. Additionally, articles that explored the components and design considerations of micro-physiological systems were reviewed to identify challenges and opportunities in drug development for challenging epilepsy cases. Results: The micro-physiological system offers a more accurate and cost-effective alternative to traditional models for assessing drug effects, toxicities, and disease mechanisms. Nevertheless, designing patient-specific models presents critical considerations, including the integration of analytical biosensors and patient-derived cells, while addressing regulatory, material, and biological complexities. Material selection, standardization, integration of vascular systems, cost efficiency, real-time monitoring, and ethical considerations are also crucial to the successful use of this technology in drug development. Conclusion: The future of organ-on-chip technology holds great promise, with the potential to integrate artificial intelligence and machine learning for personalized treatment of epileptic patients.

[1]  Han Yang,et al.  Organ-on-a-chip meets artificial intelligence in drug evaluation , 2023, Theranostics.

[2]  S. Fontana,et al.  Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models , 2023, International journal of molecular sciences.

[3]  F. Antonelli.  3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research , 2023, International journal of molecular sciences.

[4]  R. Luttge,et al.  Microenvironments Matter: Advances in Brain-on-Chip , 2023, Biosensors.

[5]  P. Parihar,et al.  Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery , 2023, Frontiers in Pharmacology.

[6]  Yuzhen Wang,et al.  Emerging trends in organ-on-a-chip systems for drug screening , 2023, Acta pharmaceutica Sinica. B.

[7]  S. Tran,et al.  Microfluidic Organ-on-A-chip: A Guide to Biomaterial Choice and Fabrication , 2023, International journal of molecular sciences.

[8]  Song Ih Ahn,et al.  Design and engineering of organ-on-a-chip , 2023, Biomedical Engineering Letters.

[9]  D. Kelly,et al.  3D organ-on-a-chip: The convergence of microphysiological systems and organoids , 2022, Frontiers in Cell and Developmental Biology.

[10]  T. Ahmed.  Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery , 2022, Biosensors and Bioelectronics: X.

[11]  T. Pandita,et al.  Breakthroughs and Applications of Organ-on-a-Chip Technology , 2022, Cells.

[12]  C. Steriade,et al.  Entering the Era of Personalized Medicine in Epilepsy Through Neuroimaging Machine Learning , 2022, Epilepsy currents.

[13]  H. S. Rho,et al.  A guide to the organ-on-a-chip , 2022, Nature Reviews Methods Primers.

[14]  D. Ingber.  Human organs-on-chips for disease modelling, drug development and personalized medicine , 2022, Nature Reviews Genetics.

[15]  I. Berindan‐Neagoe,et al.  Organ-On-A-Chip: A Survey of Technical Results and Problems , 2022, Frontiers in Bioengineering and Biotechnology.

[16]  G. Sung,et al.  Development of an Aged Full-Thickness Skin Model Using Flexible Skin-on-a-Chip Subjected to Mechanical Stimulus Reflecting the Circadian Rhythm , 2021, International journal of molecular sciences.

[17]  N. Mustafaoglu,et al.  Design and Fabrication of Organ-on-Chips: Promises and Challenges , 2021, Micromachines.

[18]  A. Miri,et al.  Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives , 2021, Pharmaceutics.

[19]  E. Perucca.  The pharmacological treatment of epilepsy: recent advances and future perspectives , 2021, Acta Epileptologica.

[20]  M. Radisic,et al.  Organs-on-a-chip models for biological research , 2021, Cell.

[21]  Ben M. Maoz.  Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system , 2021, APL bioengineering.

[22]  G. Kulsharova,et al.  Liver microphysiological platforms for drug metabolism applications , 2021, Cell proliferation.

[23]  M. Tenje,et al.  In-Line Analysis of Organ-on-Chip Systems with Sensors: Integration, Fabrication, Challenges, and Potential , 2021, ACS biomaterials science & engineering.

[24]  H. Kim,et al.  Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip , 2021, Advanced healthcare materials.

[25]  António S. Barros,et al.  Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities , 2021, Biotechnology and bioengineering.

[26]  K. Cheung,et al.  Review of Design Considerations for Brain-on-a-Chip Models , 2021, Micromachines.

[27]  Ronny Vargas,et al.  Organ-on-a-Chip systems for new drugs development , 2021, ADMET & DMPK.

[28]  Anup D. Sharma,et al.  Advances in microfluidic in vitro systems for neurological disease modeling , 2021, Journal of neuroscience research.

[29]  O. Guenat,et al.  Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane , 2021, Communications biology.

[30]  Y. Cho,et al.  Potential of Drug Efficacy Evaluation in Lung and Kidney Cancer Models Using Organ-on-a-Chip Technology , 2021, Micromachines.

[31]  Jun Yang,et al.  Three-dimensional in vitro tissue culture models of brain organoids , 2021, Experimental Neurology.

[32]  H. Fröhlich,et al.  Towards realizing the vision of precision medicine: AI based prediction of clinical drug response , 2020, Brain : a journal of neurology.

[33]  Rossana Rauti,et al.  Recent progress in translational engineered in vitro models of the central nervous system , 2020, Brain : a journal of neurology.

[34]  C. Mummery,et al.  Organs-on-chips: into the next decade , 2020, Nature Reviews Drug Discovery.

[35]  J. Lekkala,et al.  A modular brain-on-a-chip for modelling epileptic seizures with functionally connected human neuronal networks. , 2020, Biosensors & bioelectronics.

[36]  Weijia Wen,et al.  Organ-on-a-chip: recent breakthroughs and future prospects , 2020, BioMedical Engineering OnLine.

[37]  J. Abolfazli Esfahani,et al.  Analysis of oxygen transport in microfluidic bioreactors for cell culture and organ‐on‐chip applications , 2020, Engineering Reports.

[38]  Simon Rayner,et al.  3D cell culture models and organ‐on‐a‐chip: Meet separation science and mass spectrometry , 2019, Electrophoresis.

[39]  Mirza Ali Mofazzal Jahromi,et al.  Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders , 2019, Molecular Neurobiology.

[40]  Regina Luttge,et al.  The Need for Physiological Micro-Nanofluidic Systems of the Brain , 2019, Front. Bioeng. Biotechnol..

[41]  Jing Liu,et al.  Epilepsy-on-a-Chip System for Antiepileptic Drug Discovery , 2019, IEEE Transactions on Biomedical Engineering.

[42]  Fares Alahdab,et al.  Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[43]  Nicole N. Hashemi,et al.  Placenta‐on‐a‐Chip: In Vitro Study of Caffeine Transport across Placental Barrier Using Liquid Chromatography Mass Spectrometry , 2019, Global challenges.

[44]  Gebre Teklemariam Demoz,et al.  Treatment outcome and associated factors among patients with epilepsy , 2018, Scientific Reports.

[45]  Wilhelm Pfleging,et al.  Research on the Methods for the Mass Production of Multi-Scale Organs-On-Chips , 2018, Polymers.

[46]  P. Sanseau,et al.  Drug repurposing: progress, challenges and recommendations , 2018, Nature Reviews Drug Discovery.

[47]  Hafiz M.N. Iqbal,et al.  Organs-on-a-Chip Module: A Review from the Development and Applications Perspective , 2018, Micromachines.

[48]  Jae-Sung Kwon,et al.  Microfluidic Technology for Cell Manipulation , 2018, Applied Sciences.

[49]  Christopher Probst,et al.  High-throughput organ-on-a-chip systems: Current status and remaining challenges , 2018, Current Opinion in Biomedical Engineering.

[50]  Gordana Vunjak-Novakovic,et al.  Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. , 2018, Cell stem cell.

[51]  R. Peck.  Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient. , 2018, Annual review of pharmacology and toxicology.

[52]  S. Wölfl,et al.  Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites. , 2018, ACS biomaterials science & engineering.

[53]  Shu-Na Wang,et al.  Organoid technology for brain and therapeutics research , 2017, CNS neuroscience & therapeutics.

[54]  Chun-Ting Lee,et al.  3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders , 2017, Journal of Biomedical Science.

[55]  M. Radisic,et al.  Organ-on-a-chip devices advance to market. , 2017, Lab on a chip.

[56]  Jong Hwan Sung,et al.  A pumpless multi‐organ‐on‐a‐chip (MOC) combined with a pharmacokinetic–pharmacodynamic (PK–PD) model , 2017, Biotechnology and bioengineering.

[57]  S. Sisodiya,et al.  Pharmacogenomics in epilepsy , 2017, Neuroscience Letters.

[58]  Andre Levchenko,et al.  Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis. , 2016, Lab on a chip.

[59]  Hyun Jung Kim,et al.  Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological Systems , 2016, Micromachines.

[60]  A. Coppola,et al.  The challenges of treating epilepsy with 25 antiepileptic drugs. , 2016, Pharmacological research.

[61]  M. Moses,et al.  MMPs in Biology and Medicine , 2015 .

[62]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[63]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[64]  D. Elson,et al.  Optical imaging , 2020, Bioengineering Innovative Solutions for Cancer.

[65]  Alexander P. Haring,et al.  Brain-on-a-chip systems for modeling disease pathogenesis , 2020 .

[66]  Antonio F. Hernández,et al.  OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes. , 2017, ALTEX.

[67]  Mardas Daneshian,et al.  t 4 Workshop Report * State-ofthe-Art of 3 D Cultures ( Organs-ona-Chip ) in Safety Testing and Pathophysiology , 2014 .

[68]  M. Armstrong,et al.  The Genetics of Adverse Drug Reactions , 2008 .